Cytek Biosciences, Inc. (CTKB) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $4.08M | +15.9% |
| 2024 | $3.52M | -24.2% |
| 2023 | $4.65M | -52.3% |
| 2022 | $9.75M | +123.4% |
| 2021 | $4.36M | +182.1% |
| 2020 | $1.55M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $4.08M | +15.9% |
| 2024 | $3.52M | -24.2% |
| 2023 | $4.65M | -52.3% |
| 2022 | $9.75M | +123.4% |
| 2021 | $4.36M | +182.1% |
| 2020 | $1.55M | — |